SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-117865
Filing Date
2020-10-26
Accepted
2020-10-23 19:27:49
Documents
3
Period of Report
2020-10-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2032415-7_8k.htm 8-K 28754
2 EXHIBIT 5.1 tm2032415d7_ex5-1.htm EX-5.1 20390
3 GRAPHIC tm2032415d7_ex5-1img001.jpg GRAPHIC 8699
  Complete submission text file 0001104659-20-117865.txt   62556
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 201258760
SIC: 3841 Surgical & Medical Instruments & Apparatus